AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Introduction Clostridium difficile infection (CDI) is the leading cause of antibiotic-associated
diarrhea. CDI has increased in incidence and severity over the past decade, and is a …

Attention has recently been directed toward a plausible link between Clostridium difficile
infection (CDI) and proton-pump inhibitors (PPIs). However, the results of studies on the …

Importance Only a portion of hospital-acquiredClostridium difficileinfections can be traced
back to source patients identified as having symptomatic disease. Antibiotic exposure is the …

Several communities have started using probiotic-rich fermented foods as therapeutic
options with presumed medicinal powers. We now know the importance of microbiome …

Summary Background Infections with Clostridium difficile are a health threat, yet no products
are currently licensed for prevention of primary C difficile infections. Intravenous β-lactam …

Objectives: Stress ulcer prophylaxis is commonly administered to critically ill patients for the
prevention of clinically important stress-related mucosal bleeding from the upper …

BACKGROUNDClostridium difficile is the principal infectious cause of antibiotic-associated
diarrhea and accounts for 12% of hospital-acquired infections. Recent literature has shown …

Background Clostridium difficile infection (CDI) is a cause of increased morbidity and health
care costs among hospitalized patients. Proton pump inhibitors (PPIs) are mainly used for …

Objective An adverse effect of acid-suppression medications on the occurrence of
Clostridium difficile infection (CDI) has been a common finding of many, but not all studies …